Rauchstopp und Risikoreduktion-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rauchstopp und Risikoreduktion

Published:2019-06-25 Issue:4 Volume:24 Page:313-318
ISSN:0948-7034
Container-title:Gefässchirurgie
language:de
Short-container-title:Gefässchirurgie

Author:

Kröger K., ,Böhner H.,Nowak T.,Klemp U.,Pourhassan S.,Fellmer P.,Aleksic M.,Petzold T.

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s00772-019-0536-7.pdf

Reference17 articles.

1. CAPRIE Steering Committee (1996) A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348:1329–1339

2. Hiatt WR, Fowkes FG, Heizer G, Berger JS, Baumgartner I, Held P, Katona BG, Mahaffey KW, Norgren L, Jones WS, Blomster J, Millegård M, Reist C, Patel MR, EUCLID Trial Steering Committee and Investigators. (2017) Ticagrelor versus clopidogrel in symptomatic peripheral artery disease. N Eng J Med 376:32–40

3. Bonaca MP, Nault P, Giugliano RP, Keech AC, Pineda AL, Kanevsky E, Kuder J, Murphy SA, Jukema JW, Lewis BS, Tokgozoglu L, Somaratne R, Sever PS, Pedersen TR, Sabatine MS (2018) Low-density lipoprotein cholesterol lowering with Evolocumab and outcomes in patients with peripheral artery disease: insights from the FOURIER trial. Circulation 137:338–350

4. Lampert T (2013) Verbreitung des Rauchens in der Erwachsenenbevölkerung in Deutschland. Ergebnisse der Studie zur Gesundheit Erwachsener in Deutschland (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 56:802–808

5. Hennrikus D, Joseph AM, Lando HA et al (2010) Effectiveness of a smoking cessation program for peripheral artery disease patients: a randomized controlled trial. J Am Coll Cardiol 56:2105–2112

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PAVK bei Diabetikern: Interventionen und Sekundärprophylaxe;Info Diabetologie;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3